Infectious Diseases

Overview

The aim of the seven groups of this area is to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group is mainly focused on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new preventive vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. Microbiology studies mechanisms of resistance to antimicrobials, pathogenicity, taxonomy and epidemiology, and infectious diseases diagnostics.

The CRIPS group focuses on the most prevalent aspects of infections in the intensive care unit (ICU), while SODIR group works in the areas of shock, organ dysfunction and resuscitation.

There is also a group focused on infection in immunocompromised pediatric patients, and a group from the CIBBIM-Nanomedicine interested in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of medicine.

Publications

108

total

876.949

impact factor

4.665

average impact factor

Group Leader: Tomàs Pumarola

team

group-zoom

zoom

group-download

download

During 2018, we have developed projects aiming to elucidate the antimicrobial susceptibility, the mechanisms of antimicrobial resistance and population dynamics of clinically relevant pathogens such as B. pertussis, M. tuberculosis, Enterobacterales, C. trachomatis, N. gonorrhoeae, T. pallidum, S. aureus, respiratory viruses and T. cruzi among others. We have characterized a case of respiratory toxigenic diphtheria following a 30-year diphtheria-free interval in Catalonia and we have identified new antimicrobial targets and new antimicrobial molecules that may be useful to fight against multidrug resistant bacteria. We have established a viral respiratory infections surveillance programme among all the hospitals included in the Catalan Institute of Health. Finally, we have worked in the development and validation of new rapid diagnosis devices in the field of sepsis and respiratory tract infections.

51

total

184^.581

impact factor

3^.619

average impact factor

SELECTED ARTICLES

Andrés C, Peremiquel-Trillas P, Gimferrer L, Isern A, Piñana M, Rodrigo-Pendás JÁ, Codina MG, Martín MDC, Fuentes F, Rubio S, Campins-Martí M, Pumarola T, Antón A.
Genetic diversity of rhinoviruses detected at a tertiary hospital in Catalonia (Spain) during the 2014-2017 seasons.
Future Microbiol. 2018 Nov;13:1565-1573.
doi: 10.2217/fmb-2018-0151.
IF: 3.19
Rando-Segura A, Aznar ML, Moreno MM, Espasa M, Sulleiro E, Bocanegra C, Gil E, Eugénio ANE, Escartin C, Zacarias A, Vegue J, Katimba D, Vivas MC, Gabriel E, Marina MC, Mendioroz J, López MT, Pumarola T, Molina I, Tórtola MT.
Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
Emerg Infect Dis. 2018 Mar;24(3):569-572.
doi: 10.3201/eid2403.171562.
IF: 8.22
Jané M, Vidal MJ, Camps N, Campins M, Martínez A, Balcells J, Martin-Gomez MT, Bassets G, Herrera-León S, Foguet A, Maresma M, Follia N, Uriona S, Pumarola T.
A case of respiratory toxigenic diphtheria: contact tracing results and considerations following a 30-year disease-free interval, Catalonia, Spain, 2015.
Euro Surveill. 2018 Mar;23(13).
doi: 10.2807/1560-7917.ES.2018.23.13.17-00183.
IF: 7.12
Brown-Jaque M, Rodriguez Oyarzun L, Cornejo-Sánchez T, Martín-Gómez MT, Gartner S, de Gracia J, Rovira S, Alvarez A, Jofre J, González-López JJ, Muniesa M.
Detection of Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of Cystic Fibrosis Patients.
Front Microbiol. 2018 May 1;9:856.
doi: 10.3389/fmicb.2018.00856.
IF: 4.02
Gimferrer L, Andrés C, Rando A, Piñana M, Codina MG, Martin MDC, Fuentes F, Rubio S, Alcubilla P, Pumarola T, Antón A.
Evaluation of Seegene Allplex Respiratory Panel 1 kit for the detection of influenza virus and human respiratory syncytial virus.
J Clin Virol. 2018 Aug;105:31-34.
doi: 10.1016/j.jcv.2018.05.006.
IF: 3.10

View all publications